Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-19-055036
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-04 18:59:24
Reporting Period:
2019-11-04
Accepted Time:
2019-11-04 18:59:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1673772 Rapt Therapeutics Inc. RAPT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1182464 V David Goeddel C/o Rapt Therapeutics, Inc.
561 Eccles Avenue
South San Francisco CA 94080
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-04 2,463,659 $0.00 2,463,659 No 4 C Indirect By The Column Group II, LP
Common Stock Acquisiton 2019-11-04 1,166,666 $0.00 3,630,325 No 4 C Indirect By The Column Group II, LP
Common Stock Acquisiton 2019-11-04 727,008 $0.00 4,357,333 No 4 C Indirect By The Column Group II, LP
Common Stock Acquisiton 2019-11-04 625,000 $12.00 4,982,333 No 4 P Indirect By The Column Group II, LP
Common Stock Acquisiton 2019-11-04 1,454,016 $0.00 1,454,016 No 4 C Indirect By Ponoi Capital, LP
Common Stock Acquisiton 2019-11-04 145,401 $0.00 1,599,417 No 4 C Indirect By Ponoi Capital, LP
Common Stock Acquisiton 2019-11-04 145,401 $0.00 145,401 No 4 C Indirect By Ponoi Capital II, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By The Column Group II, LP
No 4 C Indirect By The Column Group II, LP
No 4 C Indirect By The Column Group II, LP
No 4 P Indirect By The Column Group II, LP
No 4 C Indirect By Ponoi Capital, LP
No 4 C Indirect By Ponoi Capital, LP
No 4 C Indirect By Ponoi Capital II, LP
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2019-11-04 14,781,963 $0.00 2,463,659 $0.00
Common Stock Series B Preferred Stock Disposition 2019-11-04 7,000,000 $0.00 1,166,666 $0.00
Common Stock Series C Preferred Stock Disposition 2019-11-04 4,362,050 $0.00 727,008 $0.00
Common Stock Series C Preferred Stock Disposition 2019-11-04 8,724,100 $0.00 1,454,016 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2019-11-04 872,410 $0.00 145,401 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2019-11-04 872,410 $0.00 145,401 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 50,000 Indirect By The Column Group II Management, LP
Footnotes
  1. At the closing of the Issuer's initial public offering, each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, and Series C-2 Preferred Stock of the Issuer automatically converted into approximately 0.166 shares of the Issuer's common stock (on an adjusted basis, after giving effect to the 1-for-6 reverse stock split of the common stock effected by the Issuer on July 19, 2019) for no additional consideration. Shares of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series C-2 Preferred Stock have no expiration date.
  2. David Goeddel is a managing partner of The Column Group II GP, LP, which is the general partner of The Column Group II, LP. Dr. Goeddel is also a managing partner of The Column Group II Management, LP. Dr. Goeddel is also a managing partner of Ponoi Management, LLC, general partner of Ponoi Capital, LP, and a managing partner of Ponoi II Management, LLC, general partner of Ponoi Capital II, LP. Dr. Goeddel may be deemed to share voting and investment power with respect to the shares reported herein and disclaims beneficial ownership of the shares except to the extent of his pecuniary interests therein.
  3. These shares are held directly by The Column Group II, LP.
  4. These shares are held directly by Ponoi Capital, LP.
  5. These shares are held directly by Ponoi Capital II, LP.
  6. These shares are held directly by The Column Group II Management, LP.